- Home
- ALHC vs FOLD Comparison
ALHC vs FOLD Comparison
Compare ALHC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALHC
- FOLD
- Stock Information
- Founded
- ALHC 2013
- FOLD 2002
- Country
- ALHC United States
- FOLD United States
- Employees
- ALHC N/A
- FOLD N/A
- Industry
- ALHC Medical Specialities
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- ALHC Health Care
- FOLD Health Care
- Exchange
- ALHC Nasdaq
- FOLD Nasdaq
- Market Cap
- ALHC 2.9B
- FOLD 2.9B
- IPO Year
- ALHC 2021
- FOLD 2007
- Fundamental
- Price
- ALHC $12.97
- FOLD $6.32
- Analyst Decision
- ALHC Buy
- FOLD Strong Buy
- Analyst Count
- ALHC 11
- FOLD 10
- Target Price
- ALHC $17.85
- FOLD $26.89
- AVG Volume (30 Days)
- ALHC 3.8M
- FOLD 4.0M
- Earning Date
- ALHC 07-30-2025
- FOLD 07-31-2025
- Dividend Yield
- ALHC N/A
- FOLD N/A
- EPS Growth
- ALHC N/A
- FOLD N/A
- EPS
- ALHC N/A
- FOLD N/A
- Revenue
- ALHC $3,335,894,000.00
- FOLD $571,160,000.00
- Revenue This Year
- ALHC $43.40
- FOLD $19.97
- Revenue Next Year
- ALHC $25.87
- FOLD $22.92
- P/E Ratio
- ALHC N/A
- FOLD N/A
- Revenue Growth
- ALHC 49.46
- FOLD 25.35
- 52 Week Low
- ALHC $7.92
- FOLD $5.51
- 52 Week High
- ALHC $21.06
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- ALHC 48.38
- FOLD 55.44
- Support Level
- ALHC $11.66
- FOLD $6.06
- Resistance Level
- ALHC $16.24
- FOLD $6.40
- Average True Range (ATR)
- ALHC 0.78
- FOLD 0.28
- MACD
- ALHC 0.14
- FOLD 0.01
- Stochastic Oscillator
- ALHC 29.14
- FOLD 49.44
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.